Hearing Disorders Clinical Trial
Official title:
Assessment of Hearing in Children Born to Rheumatic Diseased Women Treated With Antimalarial Drugs During Pregnancy
Evaluation of the hearing functions of children born to rheumatic diseased mothers who received gestational antimalarial drugs versus those didn't receive gestational antimalarials drugs compared with normal healthy children.
Rheumatic diseases are autoimmune illnesses characterized by tissue damage, caused by
abnormal immunologic reaction against own cells, tissues or organs.Many of these rheumatic
diseases preferentially occur in women during the childbearing age.
The transplacental passage of maternal antibody may result in a variety of adverse fetal
effects including thrombocytopenia, neutropenia, hemolysis and thyroid disease. Both fetal
hypo and hyper thyroidism may occur and maternal hypothyroidism particularly during the 1st
trimester is associated with impaired fetal neurological development and delayed mental and
motor development.
Hydroxychloroquine (CQ), the hydroxyl derivative of chloroquine, is an antimalarial agent
which is widely used, either alone or in combination with other agents, in the treatment of
SLE, rheumatoid arthritis (RA) and various other autoimmune diseases.
Hydroxychloroquine is safe during pregnancy, as it is not associated with an increased rate
of congenital malformations. However, isolated cases of ocular (retinal pigment deposits) and
auditory abnormalities were reported.
An increase in high-frequency hearing threshold is the earliest change in the auditory
function for most drug induced hearing losses, including the irreversible damage caused by
antimalarials.
The investigators therefore will use audiological methods for detection of hearing impairment
in children delivered for mothers receiving antimalarials during pregnancy with rheumatic
diseases.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05086809 -
Investigation of an Updated Bone-anchored Sound Processor
|
N/A | |
Enrolling by invitation |
NCT06051968 -
Effects of an Online Hearing Support for First-time Hearing Aid Users
|
N/A | |
Completed |
NCT03512951 -
Subjective Evaluation of a Sound Processing Method for Hearing Aids on Auditory Distance Perception
|
N/A | |
Terminated |
NCT02189798 -
Implantation of the HiRes90K™ Advantage Cochlear Implant With HiFocus™ Mid-Scala and Development of a Combined Electric and Acoustic Stimulation Technology in Adults With Partial Deafness
|
N/A | |
Terminated |
NCT01959152 -
Evaluation of Hearing Preservation in Adults With Partial Low-Frequency Hearing Implanted With the HiFocus™ Mid-Scala Electrode
|
N/A | |
Recruiting |
NCT06164483 -
Auditory Functions in Patients With Multiple Sclerosis
|
||
Completed |
NCT02811549 -
Benefits of the HiResolution Bionic Ear System in Adults With Asymmetric Hearing Loss
|
N/A | |
Not yet recruiting |
NCT02453633 -
Theory Based SMS Reminders - Text's Impact on Patient Attendance
|
N/A | |
Completed |
NCT01621256 -
Efficacy, Safety, and Tolerability of Ancrod in Patients With Sudden Hearing Loss
|
Phase 1/Phase 2 | |
Recruiting |
NCT06303180 -
NIDCD Otolaryngology Clinical Protocol Biospecimen Bank
|
||
Not yet recruiting |
NCT05189587 -
Home-based Transcranial Electrical Stimulation (TES) in Patients With Chronic Tinnitus
|
N/A | |
Completed |
NCT05467059 -
Evaluation of Potential Causes of Nap Modulated Tinnitus
|
||
Completed |
NCT01738490 -
Long-term Stability and Survival Rates of a Novel Oticon Medical Bone Conduction Device Implant
|
N/A | |
Completed |
NCT00486577 -
Chronic Electrical Stimulation of the Auditory Cortex for Intractable Tinnitus
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT05728203 -
Audiologic Assessment of Call Center Operators
|
||
Not yet recruiting |
NCT05222230 -
FFP3 Respirators and Ears - Effects on Middle Ear Pressure and Hearing
|
N/A | |
Recruiting |
NCT06468137 -
Follow Up of an Online Hearing Support for First-time Hearing Aid Users
|
N/A | |
Recruiting |
NCT05936034 -
Comparative Study of the Quality of Life of Patients Suffering From OTOTOXICITY Due to Chemotherapy Based on Platinum Salts Fitted With a Hearing Aid Compared to Those Not Fitted.
|
N/A | |
Recruiting |
NCT05117801 -
Evaluation of Pétale® (Small Hearing Test Equipment for Children) for the Screening of Hearing Disorders in Children From 9 Months to 3 Years Old by the General Practitioner or Pediatrician
|
N/A | |
Completed |
NCT05719610 -
Effects of Cawthorne Cooksey Exercises on Balance in Children With Hearing Deficits
|
N/A |